Back to Rankings

QNCX

Quince TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
View Chart
Current thesis
The remaining upside case is no longer tied to eDSP development after Quince said the Phase 3 NEAT study missed primary and key secondary endpoints and that it would cease clinical development, preserve cash, and explore options; upside now rests on whether the cleaned-up balance sheet and strategic review produce a value-accretive transaction [#PR-2026-01-29][#PR-2026-03-30][#PR-2026-02-09].
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Low coverage and thin liquidity can cause sharp price moves disconnected from intrinsic value.
Momentum
74
Value
41
Sentiment
0
Setup hits (3d)
— · Net —
AI TargetsBase $0.90 · Bull $2.20 · Bear $0.35
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net —
Target $83.33
Why
Momentum74 · Δ7d -
Value41 · Δ7d -17.8
Sentiment0 · Δ7d -
So what
Weak posture. Prioritize risk control and patience.
Setup hits not loaded

Load setup hits to see net bias and recent triggers.

Load setup hits
Lead driver: Momentum · See technicals
Momentum
74
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
39% active weight
Current posture
7d trendSoftening
Δ7d
-17.8
Δ21d
-17.6
Sentiment
0
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade F. Momentum 74.5 / Value 41.1 / Sentiment 0.0

Fundamentals (TTM)
As of 2026-07-17
Market Cap
$18.46M
Beta
1.24
Shares Out
977.96K
P/E (TTM) · Derived
-0.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-2.68
Rev YoY
-
EPS YoY
-214.2%
Gross Margin
-
Op Margin
-
Net Debt
$719K
Current Ratio
2.92
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology